NEW YORK – A new European diagnostics network has been initiated to support the development of new tools for infectious disease detection and diagnosis. Called the Pan European One Health Network for ...

The firms will validate histopathology biomarkers related to bladder cancer using clinical data and tissue samples captured during cystoscopy.

NEW YORK – Grail shareholders have filed a complaint with the US District Court for the Northern District of California alleging that Grail and three of its executives violated federal securities laws ...

The company recently submitted for publication data on a feline cancer assay, which could trigger a $5 million payment from a licensee.

Under the repurchase program, the company may repurchase shares through open market purchases, in privately negotiated transactions, or by other means.

Last week, readers were most interested in a story about ASCO's decision not to recommend the use of Grail's MCED test in light of NHS trial data.

German diagnostics company DiaSys Diagnostic Systems has launched its ACE FS test for the confirmatory diagnosis of sarcoidosis. Additionally, the CE-IVDR-marked test is intended for use for the ...

The Pan European One Health Network for Infectious Diseases Detection, Monitoring, and Prevention will officially commence in October and will run for four years. Notified bodies have been warning in ...

NEW YORK – A federal district court judge in South Carolina granted summary judgement in favor of Quest Diagnostics last week, unconvinced by the plaintiff's argument that a genetic test result ...

NEW YORK – Fujirebio said Monday that its Fujirebio Europe NV business has received the CE mark for its Lumipulse G pTau 217 Plasma assay under the EU's In Vitro Diagnostic Regulation. The assay is a ...

NEW YORK – The sepsis testing market has become increasingly crowded with entries from a multitude of firms, but test adoption remains lumpy as clinicians wait for more proof of clinical value. Some ...

NEW YORK – Quest Diagnostics on Tuesday announced pricing for a public offering of $500 million worth of 5 percent senior notes. The offering is expected to close on May 6, and the notes are due in ...